Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Covidien, a healthcare products company, has announced that it will implement a restructuring program beginning in fiscal 2009 to improve its cost structure and to deliver improved operational growth.
Subscribe to our email newsletter
The restructuring program, which includes projects in all four business segments and at corporate, will result in the company incurring pre-tax charges of approximately $200 million beginning in the first quarter of fiscal 2009.
Savings from the restructuring program are estimated at $50 million to $75 million on an annualized basis once the program is completed.
Richard Meelia, president and CEO of Covidien, said: This initiative will enable us to continue investing for future growth and profitability. We remain committed to making incremental investments in research and development to strengthen our portfolio and to expand into adjacent high-growth areas of the healthcare market.